Bioinformatic Design of Dendritic Cell-Specific Synthetic Promoters.

Abayomi O Johnson1,2, Susan B Fowler3, Carl I Webster4

  • 1Department of Chemical and Biological Engineering, University of Sheffield, Mappin Street, Sheffield S1 3JD, U.K.

ACS Synthetic Biology
|April 7, 2022
PubMed
Summary

Scientists designed new synthetic promoters specific to dendritic cells (DCs) for cancer immunotherapies. These promoters harness the DC transcriptional landscape to control gene expression, enabling precise vaccine development.

Related Concept Videos